U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
149124
Name Type Language
MTAU-9937A
Preferred Name English
SEMORINEMAB
USAN   INN  
Official Name English
RO7105705
Code English
IMMUNOGLOBULIN G4-KAPPA, ANTI-(HOMO SAPIENS MICROTUBULE-ASSOCIATED PROTEIN TAU (NEUROFIBRILLARY TANGLE PROTEIN, PAIRED HELICAL FILAMENT-TAU, PHF-TAU))MONOCLONAL ANTIBODY.GAMMA.4 HEAVY CHAIN (1-444) (VH (HOMO SAPIENS IGHV3-23*03 (89%) (IGHD)-IGHJ4*01) (8.
Systematic Name English
SEMORINEMAB [USAN]
Common Name English
semorinemab [INN]
Common Name English
RO-7105705
Code English
MTAU9937A
Code English
Semorinemab [WHO-DD]
Common Name English
IMMUNOGLOBULIN G4-KAPPA, ANTI-(HOMO SAPIENS MAPT (MICROTUBULE-ASSOCIATED PROTEIN TAU, TAU)), MONOCLONAL ANTIBODYGAMMA4 HEAVY CHAIN (1-444) (VH (HOMO SAPIENS IGHV3-23*03 (88.7%)-(IGHD)-IGHJ4*01 (100%)) (8.8.10) (1-117)-HOMO SAPIENS IGHG4*01 (CH1 (118-215)
Systematic Name English
IMMUNOGLOBULIN G4, ANTI-(HUMAN TAU PROTEIN) (HUMAN-MUS MUSCULUS MONOCLONAL RO7105705 .GAMMA.4-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL RO7105705 .KAPPA.-CHAIN, DIMER
Systematic Name English
Code System Code Type Description
NCI_THESAURUS
C174790
Created by admin on Wed Apr 02 01:37:03 GMT 2025 , Edited by admin on Wed Apr 02 01:37:03 GMT 2025
PRIMARY
INN
11024
Created by admin on Wed Apr 02 01:37:03 GMT 2025 , Edited by admin on Wed Apr 02 01:37:03 GMT 2025
PRIMARY
SMS_ID
300000005946
Created by admin on Wed Apr 02 01:37:03 GMT 2025 , Edited by admin on Wed Apr 02 01:37:03 GMT 2025
PRIMARY
CAS
2159141-27-0
Created by admin on Wed Apr 02 01:37:03 GMT 2025 , Edited by admin on Wed Apr 02 01:37:03 GMT 2025
PRIMARY
DRUG BANK
DB15234
Created by admin on Wed Apr 02 01:37:03 GMT 2025 , Edited by admin on Wed Apr 02 01:37:03 GMT 2025
PRIMARY
USAN
GH-168
Created by admin on Wed Apr 02 01:37:03 GMT 2025 , Edited by admin on Wed Apr 02 01:37:03 GMT 2025
PRIMARY
FDA UNII
O8DG8VI95O
Created by admin on Wed Apr 02 01:37:03 GMT 2025 , Edited by admin on Wed Apr 02 01:37:03 GMT 2025
PRIMARY
ACTIVE MOIETY
SEMORINEMAB
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966